Nima Nassehi

Novel bivalent ligands carrying potential antinociceptive effects by targeting putative mu opioid receptor and chemokine receptor CXCR4 heterodimers.

D. Selley, S. Stevens Negus, Hongguang Ma, 2022, Bioorganic chemistry.

Bivalent Ligand Aiming Putative Mu Opioid Receptor and Chemokine Receptor CXCR4 Dimers in Opioid Enhanced HIV-1 Entry.

Bethany A. Reinecke, D. Selley, J. An, 2020, ACS medicinal chemistry letters.

A Journey through Diastereomeric Space: The Design, Synthesis, In Vitro and In Vivo Pharmacological Activity, and Molecular Modeling of Novel Potent Diastereomeric MOR Agonists and Antagonists

D. Selley, K. Rice, T. Prisinzano, 2022, Molecules.

ArticleA Journey Through Diastereomeric Space: The Design

D. Selley, K. Rice, T. Prisinzano, 2022 .

Structure-Based Design and Development of Chemical Probes Targeting Putative MOR-CCR5 Heterodimers to Inhibit Opioid Exacerbated HIV-1 Infectivity.

Boshi Huang, D. Selley, P. Knapp, 2021, Journal of medicinal chemistry.

Psychedelic-like Properties of Quipazine and Its Structural Analogues in Mice.

J. González-Maeso, M. de la Fuente Revenga, M. Dukat, 2021, ACS chemical neuroscience.

Role of efficacy as a determinant of locomotor activation by mu‐opioid receptor (MOR) ligands in female and male mice. II. Effects of novel MOR‐selective phenylmorphans with high‐to‐low MOR efficacy

Eugene S. Gutman, D. Selley, A. Sulima, 2023, Pharmacology research & perspectives.